Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):49-56. Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested casecontrol study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition. Nimptsch K, Rohrmann S, Nieters A, Linseisen J. Division of Cancer Epidemiology, German Cancer Research Center, Im Neuenhe...

Young Indian women may be at risk of poor bone health due to malnutrition. The aim this study was examine the effects on metabolism a nutritional supplement in aged 25 44. protein-rich beverage powder fortified with multi-micronutrients including calcium (600 mg), vitamin D (400 IU), and K (55 mcg) per daily serving, while placebo low-protein non-fortified isocaloric powder. This 6-month random...

It has been reported that there is an intimate relationship between diabetes and bone metabolism including undercarboxylated osteocalcin (ucOC). In contrast, data on the relationship between ucOC and glucose metabolism are limited in type 2 diabetes. We recruited 50 Japanese patients with type 2 diabetes, and examined the association with ucOC on the insulin secretion, evaluated by both glucago...

OBJECTIVE Bone-derived undercarboxylated osteocalcin regulates insulin secretion and sensitivity in mice, and reduced serum total osteocalcin (TOC) is associated with diabetes in humans. However, the relationship between TOC levels and other cardiovascular risk factors is uncertain. We sought to determine whether serum TOC is associated with metabolic syndrome and its components in older men. ...

Undercarboxylated osteocalcin (ucOC) is a marker of vitamin K deficiency. In addition, ucOC reflects bone metabolic turnover besides vitamin K sufficiency status. Increased ucOC level is considered a predictor of proximal femoral fracture. Eldecalcitol has been reported to strongly influence bone metabolism as compared with the conventional vitamin D supplementation. In this study, we examined ...

s | 15 Conclusion: This is a first report associating DNA methylation signature with abstinence in alcoholics treated with acamprosate. Future studies are needed to investigate the value of this association as a potential biomarker of acamprosate response in treatment-seeking alcoholics. PM322 The risk factors of low bone mineral density in male alcoholic patients: cross-sectional study Tadasu ...